Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

NCT00269477 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company